Cornerstone Wealth Group, LLC Gilead Sciences, Inc. Transaction History

Cornerstone Wealth Group, LLC

$1.29 Billion
Q3 2024

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 29, 2024	SELL	$73.27 - $83.09 $2.44 Million - $2.76 Million	-33,254 Reduced 47.81%	36,295 $2.94 Million
Q3 2023 Oct 18, 2023	SELL	$73.94 - $80.67 $66,324 - $72,360	-897 Reduced 1.27%	69,549 $5.21 Million
Q2 2023 Aug 02, 2023	BUY	$76.01 - $86.7 $49,102 - $56,008	646 Added 0.93%	70,446 $5.43 Million
Q1 2023 Apr 25, 2023	SELL	$77.31 - $88.08 $1.06 Million - $1.21 Million	-13,685 Reduced 16.39%	69,800 $5.79 Million
Q4 2022 Jan 25, 2023	SELL	$62.32 - $89.47 $28,916 - $41,514	-464 Reduced 0.55%	83,485 $0
Q3 2022 Oct 19, 2022	BUY	$59.54 - $68.01 $5 Million - $5.71 Million	83,949 New	83,949 $5.18 Million
Q1 2022 Apr 25, 2022	SELL	$57.92 - $72.58 $2.8 Million - $3.51 Million	-48,352 Closed	0 $0
Q4 2021 Jan 25, 2022	BUY	$64.88 - $73.64 $127,229 - $144,408	1,961 Added 4.23%	48,352 $3.51 Million
Q3 2021 Oct 29, 2021	BUY	$67.69 - $73.03 $3.14 Million - $3.39 Million	46,391 New	46,391 $3.24 Million
Q3 2020 Oct 27, 2020	SELL	$62.1 - $78.08 $2.16 Million - $2.72 Million	-34,810 Closed	0 $0
Q2 2020 Jul 27, 2020	BUY	$72.34 - $84.0 $76,391 - $88,704	1,056 Added 3.13%	34,810 $2.68 Million
Q1 2020 May 06, 2020	SELL	$62.63 - $80.22 $275,634 - $353,048	-4,401 Reduced 11.53%	33,754 $2.52 Million
Q4 2019 Jan 28, 2020	SELL	$61.62 - $67.78 $119,481 - $131,425	-1,939 Reduced 4.84%	38,155 $2.48 Million
Q3 2019 Nov 05, 2019	BUY	$62.51 - $69.0 $1.23 Million - $1.36 Million	19,679 Added 96.39%	40,094 $2.54 Million
Q2 2019 Aug 08, 2019	BUY	$61.87 - $69.38 $1.26 Million - $1.42 Million	20,415 New	20,415 $1.38 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.2 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.09 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.72 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.57 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Wealth Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Wealth Group, LLC with notifications on news.

Account